Effect of singing lessons on physical activity in patients with Chronic Obstructive Pulmonary Disease (COPD)

ISRCTN	ISRCTN39714922
DOI	https://doi.org/10.1186/ISRCTN39714922
Protocol serial number	V3
Sponsor	Imperial College London (UK)
Funders	National Institute of Health Research (NIHR) Respiratory Biomedical Research Unit (BRU) (UK) - run jointly by:, Royal Brompton & Harefield NHS Foundation Trust (UK), Imperial College London, National Heart & Lung Institute (NHLI) (UK)

Prospectively registered

Protocol

Statistical analysis plan

Results

Individual participant data

Plain English summary of protocol

Not provided at time of registration

Dr Nicholas Hopkinson
Scientific

Royal Brompton Hospital
Fulham Rd
London
SW3 6NP
United Kingdom

Primary study design	Interventional
Study design	Single-blind prospective randomised controlled trial.
Secondary study design	Randomised controlled trial
Study type	Participant information sheet
Scientific title	Effect of singing lessons on physical activity in patients with COPD: a prospective, single-blind, randomised controlled trial
Study objectives	That 8 weeks of twice weekly vocal coaching will improve daily physical activity in patients with Chronic Obstructive Pulmonary Disease (COPD) compared to a control group taking part in a film club.
Ethics approval(s)	The Brompton, Harefield & NHLI Research Ethics Committee, 15/12/2009, ref: 07/H0708/900
Health condition(s) or problem(s) studied	Chronic Obstructive Pulmonary Disease (COPD)
Intervention	Patients will be randomised to receive either: 1. Singing lessons twice per week for 8 weeks 2. Film club once per week for 8 weeks Participants will be followed for 1 week after the end of the program.
Intervention type	Other
Primary outcome measure(s)	Daily physical activity assessed using the SenseWear armband at one week after the end of the program
Key secondary outcome measure(s)	1. Hospital Anxiety Depression (HAD) score 2. COPD Assessment Test (CAT) score 3. Shuttle walk distance All outcomes will be assessed 1 week after the end of the program
Completion date	01/05/2011

Participant type(s)	Patient
Age group	Adult
Sex	All
Target sample size at registration	30
Key inclusion criteria	1. Patients with COPD with MRC dyspnea score >3/5 2. Either sex, aged >21 years
Key exclusion criteria	1. Patients with a life expectancy of <3 months 2. Patients where a diagnosis of primary hyperventilation has been made i.e. with normal lung function test results 3. Other co-morbidities will be permitted unless they are likely to interfere directly with participation in the study
Date of first enrolment	01/12/2010
Date of final enrolment	01/05/2011

Royal Brompton Hospital

London
SW3 6NP
United Kingdom

Individual participant data (IPD) Intention to share	No
IPD sharing plan summary	Not provided at time of registration
IPD sharing plan

Output type	Details	Date created	Date added	Peer reviewed?	Patient-facing?
Results article	results	13/11/2012		Yes	No
Participant information sheet	Participant information sheet	11/11/2025	11/11/2025	No	Yes